APP
TENX icon

Avantax Planning Partners’s Tenax Therapeutics TENX Stock Holding History

Avantax Planning Partners’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-125
Closed -$2.99K – 384
2023
Q3 		$2.99K Sell
125
-63
-34% -$1.6K ﹤0.01% 361
2023
Q2 		$4.5K Buy
188
+63
+50% +$1.68K ﹤0.01% 367
2023
Q1 		$4.65K Buy
+125
New +$13K ﹤0.01% 371
2018
Q4 		– Hold
0
– – – 1095
2018
Q3 		– Hold
0
– – – 1465
2018
Q2 		– Hold
0
– – – 1341
2018
Q1 		– Hold
0
– – – 1865

Other funds holding TENX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Avantax Planning Partners's TENX Position: Q4 2023 in Review

Avantax Planning Partners sold out of Tenax Therapeutics (TENX) in Q4 2023, closing a stake of 125 shares — an estimated $2.99K sold.

Avantax Planning Partners first reported a position in TENX in Q1 2023 and held it in 3 quarters. The position peaked at $4.65K in Q1 2023. 16 funds tracked by Wall St. Rank hold TENX as of Q4 2023.

  • Avantax Planning Partners reported no remaining Tenax Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Avantax Planning Partners sold 125 Tenax Therapeutics shares in Q4 2023, an estimated $2.99K.
  • Avantax Planning Partners first reported a position in Tenax Therapeutics in Q1 2023 and held it in 3 quarters.
  • Avantax Planning Partners's Tenax Therapeutics position peaked at $4.65K in Q1 2023.
  • 16 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2023.

Based on Avantax Planning Partners's 13F filing for Q4 2023, filed 9 Feb 2024.